MAM Domain Containing 2 (MAMDC2) Affects Invasion and Metastasis of Human Gastric Cancer
Authors:
Open Access
- 1 May 2025
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 18, 679-693
Abstract
Background: Gastric cancer (GC) is the fifth most prevalent cancer worldwide and the fourth leading cause of cancer-related mortality. MAM Domain Containing 2 (MAMDC2) has been involved in many cancers. However, the impact of MAMDC2 on gastric cancer was unclear. This study aimed to investigate the role and mechanism of MAMDC2 in gastric cancer. Methods: Differential genes in gastric cancer are analyzed by GEO, TCGA, MSigDB database, R-packet limma, and Wilcoxon test. Survival analysis is performed through the R package survival. Construct a PPI network through the STRING database. Enrichment analysis is performed by Metascape. The infiltration level of gastric cancer immune cells is calculated by CIBERSORT. In addition, the expression of MAMDC2 was analyzed by immunohistochemistry and quantitative real-time polymerase chain reaction (RT-qPCR). siMAMDC2 was used to knock down the specific gene. Cell counting kit-8 (CCK-8) assay, colony formation assay, and cell migration were applied to evaluate the function of MAMDC2 in gastric cancer cells. Results: In the present study, we revealed a significant upregulation of MAMDC2 in gastric cancer tissues and cells. Knocking down MAMDC2 inhibited the proliferation and migration of gastric cancer cells, while overexpression of MAMDC2 produced the opposite results. Furthermore, MAMDC2 may be an independent factor in poor prognosis in gastric cancer patients. Conclusion: These results illustrated that MAMDC2 promoted the proliferation and migration of gastric cancer cells. The newly identified MAMDC2 provides novel insight into the pathogenesis of gastric cancer.Keywords
This publication has 53 references indexed in Scilit:
- Exosome‐derived ANXA9 functions as an oncogene in breast cancerThe Journal of Pathology: Clinical Research, 2023
- Targeted Therapies in Advanced Gastric CancerCurrent Treatment Options in Oncology, 2020
- Annexin A10 is a novel prognostic biomarker of papillary thyroid cancerIrish Journal of Medical Science (1971 -), 2020
- Serum biomarker panels for the diagnosis of gastric cancerCancer Medicine, 2019
- Polymorphism in ovine ANXA9 gene and the physio‐chemical properties and the fraction of protein in milkJournal of the Science of Food and Agriculture, 2018
- Progress in gastric cancerUpdates in Surgery, 2018
- Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinibCancer Medicine, 2017
- Aktuelle Biomarker beim MagenkarzinomDer Pathologe, 2017
- Gastric cancer: Asia and the worldGastric Cancer, 2017
- Gastric cancer epidemiology and risk factorsJournal of Surgical Oncology, 2012